Principle Wealth Partners LLC Gilead Sciences, Inc. Transaction History

Principle Wealth Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $50,106 - $61,103	-700 Reduced 15.99%	3,677 $269,000
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $46,212 - $50,418	625 Added 16.66%	4,377 $328,000
Q2 2023 Jul 31, 2023	BUY	$76.01 - $86.7 $49,406 - $56,355	650 Added 20.95%	3,752 $289,000
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $193,316 - $277,535	3,102 New	3,102 $266,000
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $197,402 - $222,334	-3,420 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $15,696 - $19,669	-271 Reduced 7.34%	3,420 $203,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $129 - $147	2 Added 0.05%	3,691 $268,000
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $135 - $146	2 Added 0.05%	3,689 $258,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $34,845 - $38,073	-549 Reduced 12.96%	3,687 $254,000
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $30,120 - $34,366	502 Added 13.44%	4,236 $274,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $211,531 - $241,029	3,734 New	3,734 $218,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $67,813 - $85,263	-1,092 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $78,995 - $91,728	1,092 New	1,092 $84,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Principle Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Principle Wealth Partners LLC with notifications on news.